However, conditions are ripe for Congress to defy this inertia by passing the Treat and Reduce Obesity Act. This crucial bill ...

Some Rice University researchers have partnered with other institutions to continue bioelectrical implant treatment ...

John M. Burke, MD, examines how new obesity treatments, such as GLP-1 agonists, might influence future cancer rates.

The cost of taking weekly injections of popular anti-obesity medications liraglutide (Saxenda) or semaglutide (Wegovy) ...

Parcel Health stands out as a key player in providing innovative packaging solutions for compounding pharmacies. Parcel Health's eco-friendly paper pill bottles ensure the stability and integrity of ...

Regeneron's CSO George Yancopoulos warns that GLP-1 weight-loss drugs like Ozempic may lead to rapid muscle loss, increasing ...

Anchor] Obesity treatments, which have gained popularity through overseas celebrities and social media, will also be released ...

As obesity clinical trials evolve, there is a growing emphasis on how decentralisation and new technologies can play a role.

Popular weight-loss medications including Ozempic and Wegovy contain a drug that seems to decrease cravings for food and ...

Still, more than a quarter of employers are considering adding coverage for GLP-1 drugs for weight loss in 2025 or 2026, ...

Novo Nordisk’s Wegovy and Eli Lilly’s (LLY) Zepbound weight loss medications that are used to treat obesity have proven to be extremely popular, resulting in supply shortages. A Reversal of ...

A Carnegie Mellon University-led team of researchers has secured an award of up to $34.9 million(opens in new window) from ...